Africa Injectable Drugs Market
- 2026 年市場規模
- USD 674.3 Bn
- 2033 年預估規模
- USD 1,176.6 Bn
- 年複合成長率 CAGR
- 8.3%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Africa Injectable Drugs Market, By Molecule Type (Large Molecule and Small Molecule), By Route of Administration (Intravenous, Intramuscular, Sub-cutaneous, and Others), By End User (Hospitals, Specialty Clinics, and Others), By Geography (South Africa, North Africa, and Central Africa)
報告摘要
Injectable drugs are injected by various routes of administration, such as intravenous, intramuscular, sub-cutaneous, etc. to treat a number of diseases such as cardiovascular, respiratory, cancer, etc. Healthcare professionals can inject many medications into different parts of the body. They will decide the most appropriate route of access depending on the situation.
Market Dynamics
Rapid therapeutic effect of injectable drugs is leads to increase the demand for the injectable products. Thus, key market players are engaged in enhancing manufacturing facilities of pharmaceutical products and strengthening their market position in Africa. This, in turn, is expected to drive the market growth. For instance, the African Union Commission (AUC) and the United Nations Industrial Development Organization (UNIDO) developed a business plan to accelerate the implementation of the Pharmaceutical Manufacturing Plan for Africa (PMPA), with funding from the German government. Moreover, injectable drugs offer potential benefits to patients with human immunodeficiency virus (HIV) on anti-retroviral therapy (ART) in low-income settings in sub-Saharan Africa. This in turn to increase usage of injectable drugs to treat HIV patients and thereby drive the growth of market in Africa. Furthermore, surge in presence of branded formulations is anticipated to drive the growth of market. For instance, branded formulations for bupivacaine injection such as Macaine HCL, (0.5% for spinal injection), Macaine HCL, (0.5% for injection with Dextrose), and Macaine HCL, (0.5% injection) are available in African countries, majorly in South Africa. Major manufacturers in Africa such as Pharma-Q Holdings (Pty) Ltd. and Adcock Ingram Limited offer bupivacaine injection in South Africa and other countries in Africa. In addition, manufactures operating in the market are appointing a distributors and thus increases the number of suppliers. This in turn to propel the growth of market. For instance, online distributors/pharmacies such as Seif Pharmacy in Egypt offers Isoptin (5 mg / 2ml) in the country. Pharmaceutical suppliers such as Pharmachemie (Pty) Ltd. and Sanofi-Aventis South Africa (Pty) Ltd. supply Fludarabine brands to the Department of Health, South Africa
Key features of the study
• This report provides an in-depth analysis of Africa injectable drugs market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in Africa injectable drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Apotex Inc., Fresenius Kabi India Pvt. Ltd., Hikma Pharmaceuticals PLC, Pfizer Inc., Bristol-Myers Squibb Company, Gland Pharma Limited, hameln pharma GmBH, Merck & Co., Inc., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, and PANPHARMA S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Africa injectable drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing Africa injectable drugs market
Market Segmentation
• By Molecule Type
o Large Molecule
o Small Molecule
• By Route of Administration
o Intravenous
o Intramuscular
o Sub-cutaneous
o Others
• By End User
o Hospitals
o Specialty Clinics
o Others
• By Region
o South Africa
o North Africa
o Central Africa
• Key Players Insights
o Apotex Inc.
o Fresenius Kabi India Pvt. Ltd.
o Hikma Pharmaceuticals PLC
o Pfizer Inc.
o Bristol-Myers Squibb Company
o Gland Pharma Limited
o hameln pharma gmbh
o Merck & Co., Inc.
o AbbVie Inc.
o Sun Pharmaceutical Industries Ltd.
o Aurobindo Pharma
o PANPHARMA S.A.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Molecule Type
Market Snapshot, By Route of Administration
Market Snapshot, By End User
Market Snapshot, By Country/Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Opportunity
o Impact Analysis
o Key Highlights
o Product Launch
o PEST Analysis
o List of Distributors
o Regulatory Scenario
o Mergers and Acquisitions
4. Africa Injectable Drugs Market, By Molecule Type, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Large Molecule
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Small Molecule
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Africa Injectable Drugs Market, By Route of Administration, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Intramuscular
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Sub-cutaneous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Africa Injectable Drugs Market, By End User, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2033
Regional Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Specialty Clinics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Africa Injectable Drugs Market, By Country/Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2033
Regional Trends
o North Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
o Central Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
o South Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Molecule Type, 2021-2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Bn)
8. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
Apotex Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Fresenius Kabi India Pvt. Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Hikma Pharmaceuticals PLC
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Pfizer Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Bristol-Myers Squibb Company
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Gland Pharma Limited
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
hameln pharma gmbh
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Merck & Co., Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
AbbVie Inc.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Sun Pharmaceutical Industries Ltd.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
Aurobindo Pharma
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
PANPHARMA S.A.
o Company Highlights
o Product Portfolio
o Key Highlights
o Financial Performance
o Strategies
o Analyst Views
9. Section
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們